192 related articles for article (PubMed ID: 25125625)
1. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
Flatley E; Chen AI; Zhao X; Jaffe ES; Dunlap JB; Pittaluga S; Abdullah S; Olson SB; Spurgeon SE; Fan G
Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
[TBL] [Abstract][Full Text] [Related]
2. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
3. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
4. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Chapiro E; Pramil E; Diop M; Roos-Weil D; Dillard C; Gabillaud C; Maloum K; Settegrana C; Baseggio L; Lesesve JF; Yon M; Jondreville L; Lesty C; Davi F; Le Garff-Tavernier M; Droin N; Dessen P; Algrin C; Leblond V; Gabarre J; Bouzy S; Eclache V; Gaillard B; Callet-Bauchu E; Muller M; Lefebvre C; Nadal N; Ittel A; Struski S; Collonge-Rame MA; Quilichini B; Fert-Ferrer S; Auger N; Radford-Weiss I; Wagner L; Scheinost S; Zenz T; Susin SA; Bernard OA; Nguyen-Khac F; ;
Blood; 2019 Nov; 134(21):1821-1831. PubMed ID: 31527074
[TBL] [Abstract][Full Text] [Related]
7. B-cell prolymphocytic leukemia carrying t(8;14)(q24;q32), associated with both autoimmune hemolytic anemia and pure red cell aplasia.
Iioka F; Akasaka T; Hayashida M; Okumura A; Ohno H
J Clin Exp Hematop; 2014; 54(3):219-24. PubMed ID: 25501113
[TBL] [Abstract][Full Text] [Related]
8. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
9. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
Merchant S; Schlette E; Sanger W; Lai R; Medeiros LJ
Arch Pathol Lab Med; 2003 Mar; 127(3):305-9. PubMed ID: 12653573
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations.
Damlaj M; Al Balwi M; Al Mugairi AM
Leuk Lymphoma; 2018 Mar; 59(3):739-742. PubMed ID: 28695755
[No Abstract] [Full Text] [Related]
11. Expression of c-myc oncoprotein in chronic T cell leukemias.
Maljaie SH; Brito-Babapulle V; Matutes E; Hiorns LR; De Schouwer PJ; Catovsky D
Leukemia; 1995 Oct; 9(10):1694-9. PubMed ID: 7564512
[TBL] [Abstract][Full Text] [Related]
12. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
13. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
[TBL] [Abstract][Full Text] [Related]
15. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
Schlette E; Bueso-Ramos C; Giles F; Glassman A; Hayes K; Medeiros LJ
Am J Clin Pathol; 2001 Apr; 115(4):571-81. PubMed ID: 11293906
[TBL] [Abstract][Full Text] [Related]
16. B-prolymphocytic leukemia: Is it time to retire this entity?
El Hussein S; Khoury JD; Medeiros LJ
Ann Diagn Pathol; 2021 Oct; 54():151790. PubMed ID: 34293709
[TBL] [Abstract][Full Text] [Related]
17. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
18. An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia.
Bell S; Lattanzio N; Braham J; Campdesuner V; Abdelal Q; Vartanov A; Pelayo M
J Investig Med High Impact Case Rep; 2021; 9():2324709621990767. PubMed ID: 33533282
[TBL] [Abstract][Full Text] [Related]
19. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
